Dr Emma Cheetham
Director, Intellectual Property
Emma is a fully qualified European Patent Attorney with over 20 years’ experience in the pharmaceutical industry.
Emma has a deep knowledge of patenting compounds in the natural product area gained from building established portfolios for the first approved cannabinoid medicines. During her time at Jazz Pharmaceuticals, formerly GW Pharmaceuticals, she was instrumental in generating an impressive patent portfolio for multiple sclerosis drug, Sativex and more recently the epilepsy medicine Epidiolex, with over 20 patents listed in the Orange Book in the US and strong protection worldwide.
